Paper10987662
Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans.
Kobaek-Larsen M and 4 others. Comp Med, 2000. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Papers, record 10987662. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10987662
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Colorectal Neoplasms | Major topic |
| Disease Models, Animal | Major topic |
| Animals | |
| Female | |
| Genetic Predisposition to Disease | |
| Humans | |
| Male | |
| Mice | |
| Mice, Mutant Strains | |
| Rats | |
| Rats, Mutant Strains |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41624846 | The paradigm shift: re-evaluating preclinical animal models for colorectal cancer in the precision medicine era. | Front Immunol | 2025 | https://conductscience.org/library/papers/41624846 | PubMed |
| 40985211 | Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. | Chem Rev | 2025 | https://conductscience.org/library/papers/40985211 | PubMed |
| 40386616 | Bacillus velezensis inhibits azoxymethane/dextran sulphate sodium induced colitis associated colorectal cancer via the small molecule HeLM. | J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40386616 | PubMed |
| 39800835 | Susceptibility of different mice species to chemical induction of colorectal cancer by 1,2-dimethylhydrazine. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/39800835 | PubMed |
| 38526618 | Review of Animal Models of Colorectal Cancer in Different Carcinogenesis Pathways. | Dig Dis Sci | 2024 | https://conductscience.org/library/papers/38526618 | PubMed |
| 38236535 | Azoxymethane/Dextran Sodium Sulfate (AOM/DSS) Model of Colorectal Cancer. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/38236535 | PubMed |
| 38213952 | Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulation. | Mol Ther Nucleic Acids | 2023 | https://conductscience.org/library/papers/38213952 | PubMed |
| 37332609 | Mouse models in colon cancer, inferences, and implications. | iScience | 2023 | https://conductscience.org/library/papers/37332609 | PubMed |
| 37248173 | Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer. | Intest Res | 2023 | https://conductscience.org/library/papers/37248173 | PubMed |
| 35864492 | Establishment of a piglet model for peritoneal metastasis of ovarian cancer. | J Transl Med | 2022 | https://conductscience.org/library/papers/35864492 | PubMed |
| 34016083 | Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34016083 | PubMed |
| 33916402 | Animal Models of Colorectal Cancer: From Spontaneous to Genetically Engineered Models and Their Applications. | Vet Sci | 2021 | https://conductscience.org/library/papers/33916402 | PubMed |
| 32253687 | Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review. | Updates Surg | 2020 | https://conductscience.org/library/papers/32253687 | PubMed |
| 30080930 | Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery. | J Surg Oncol | 2018 | https://conductscience.org/library/papers/30080930 | PubMed |
| 28315775 | Assessment of histone tail modifications and transcriptional profiling during colon cancer progression reveals a global decrease in H3K4me3 activity. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28315775 | PubMed |
| 26295972 | Colorectal cancer models for novel drug discovery. | Expert Opin Drug Discov | 2015 | https://conductscience.org/library/papers/26295972 | PubMed |
| 26028820 | Time course of the incidence/multiplicity and histopathological features of murine colonic dysplasia, adenoma and adenocarcinoma induced by benzo[a]pyrene and dextran sulfate sodium. | J Toxicol Pathol | 2015 | https://conductscience.org/library/papers/26028820 | PubMed |
| 25861131 | In Vivo Detection of Rat Colorectal Cancers by using a Dual-Wavelength Excitation Method. | Acta Histochem Cytochem | 2014 | https://conductscience.org/library/papers/25861131 | PubMed |
| 23748471 | Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. | Clin Exp Metastasis | 2013 | https://conductscience.org/library/papers/23748471 | PubMed |
| 23136993 | Bilobar colorectal liver metastases: a new model for preclinical studies. | Int J Exp Pathol | 2012 | https://conductscience.org/library/papers/23136993 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10987662
GET https://conductscience.org/api/papers/v1/10987662/cited_by?page=2